Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1798-1800

  Wägner, Ana María ^a,c   Pérez, Antonio ^a   Sánchez Quesada, Jose Luis ^a   Ordóñez Llanos, Jordi ^a,b  

^a Hospital Sant Pau   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE CLASSIFICATION; DYSLIPIDEMIA; ENZYME ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 21544445263     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1798     Document Type: Article

References (14)

1. Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S: Ratio of triglyceride to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 23:1679-1685, 2000
2. Hanak V, Muñoz J, Teague J, Stanley A, Bittner V: Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol 94:219-222, 2004
3. Wagner AM, Jorba O, Rigla M, Alonso E, Ordoñez-Llanos J, Pérez A: LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol 39:215-220, 2002
4. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2496, 2001
5. American Diabetes Association: Management of dyslipidemia in adults with diabetes. Diabetes Care 27 (Suppl. 1): 568-571, 2004
6. Maruyama C, Imamura K, Teramoto T: Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 10: 186-191, 2003
7. Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PW, Massov T, Schaeffer E: Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 42:515-523, 1996
8. Wägner AM, Pérez A, Calvo F, Bonet R, Castellví A, Ordóñez J: Apolipoprotein B identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diabetes Care 22:812-817, 1999
9. Altman DG. Some common problems in medical research. In Practical Statistics for Medical Research. Altman DG, Ed. New York, Chapman and Hall, 1991, p. 396-439
10. Ortolá J, Castineiras MJ, Fuentes-Arderiu X: Biological variation data applied to the selection of serum lipid ratios used as risk markers of coronary heart disease. Clin Chem 38:56-59, 1992
11. Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G: Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361: 777-780, 2003
12. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026-2033, 2001
13. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH: International Federation of Clinical Chemistry standardization project for measurement of apolipoproteins A-I and B: comparability of apolipoprotein B values by use of International Reference Material. Clin Chem 40:586-592, 1994
14. Wagner AM, Pérez A, Zapico E, Ordóñez-Llanos J: Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients. Diabetes Care 26:2048-2051, 2003